View Item 

Show simple item record

Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver
dc.contributor.authorLerut, Janen_US
dc.contributor.authorMergental, Hyneken_US
dc.contributor.authorKahn, Delawiren_US
dc.contributor.authorAlbuquerque, Luizen_US
dc.contributor.authorMarrero, Juanen_US
dc.contributor.authorVauthey, Jean Nicolasen_US
dc.contributor.authorPorte, Robert Jen_US
dc.date.accessioned2011-11-10T15:37:44Z
dc.date.available2012-12-03T21:17:30Zen_US
dc.date.issued2011-10en_US
dc.identifier.citationLerut, Jan; Mergental, Hynek; Kahn, Delawir; Albuquerque, Luiz; Marrero, Juan; Vauthey, Jean Nicolas; Porte, Robert J (2011). "Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver ." Liver Transplantation 17(S2): S90-S97. <http://hdl.handle.net/2027.42/87077>en_US
dc.identifier.issn1527-6465en_US
dc.identifier.issn1527-6473en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87077
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titlePlace of liver transplantation in the treatment of hepatocellular carcinoma in the normal liveren_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Hepatology, University of Michigan, Ann Harbor, MIen_US
dc.contributor.affiliationotherStarzl Abdominal Transplant Unit, St. Luc University Hospital, Catholic University of Louvain, Brussels, Belgiumen_US
dc.contributor.affiliationotherLiver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdomen_US
dc.contributor.affiliationotherDepartment of Surgery, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africaen_US
dc.contributor.affiliationotherDigestive Tract Transplantation Unit, Clinic Hospital, University of São Paulo, São Paulo, Brazilen_US
dc.contributor.affiliationotherLiver Surgical Service, MD Anderson Cancer Center, Houston, TXen_US
dc.contributor.affiliationotherSection of Hepato‐Pancreato‐Biliary Surgery and Liver Transplantation, Department of Surgery, University Medical Center Groningen, Groningen, the Netherlandsen_US
dc.contributor.affiliationotherStarzl Abdominal Transplant Unit, St. Luc University Hospital, Catholic University of Louvain, 10 Avenue Hippocrate, Brussels, Belgium 1200en_US
dc.identifier.pmid21796760en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87077/1/22393_ftp.pdf
dc.identifier.doi10.1002/lt.22393en_US
dc.identifier.sourceLiver Transplantationen_US
dc.identifier.citedreferenceCherqui D, Boudjema K, Celebic A, Laurent A, Roudot‐Thoraval F. Résection hépatique pour carcinome hépatocellulaire sur foie sain et pathologique en France. Résultats de l'enquête AFC sur la période 1990‐2005. In: Boudjema K, Cherqui D, eds. Cancer Hépatocellulaire. Rueil‐Malmaison, France: Wolters Kluwer; 2006: 183 ‐ 218.en_US
dc.identifier.citedreferenceRahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453 ‐ 469.en_US
dc.identifier.citedreferenceTrevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non‐cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42: 341 ‐ 347.en_US
dc.identifier.citedreferenceLencioni R, Crocetti L, De Simone P, Filipponi F. Loco‐regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects. Transpl Int 2010; 23: 698 ‐ 703.en_US
dc.identifier.citedreferenceHwang S, Moon DB, Lee SG. Liver transplantation and conventional surgery for advanced hepatocellular carcinoma. Transpl Int 2010; 23: 723 ‐ 727.en_US
dc.identifier.citedreferenceBhoori S, Sposito C, Germini A, Coppa J, Mazzaferro V. The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis. Transpl Int 2010; 23: 712 ‐ 722.en_US
dc.identifier.citedreferenceSasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H, Iwanaga T. Influence of coexisting cirrhosis on long‐term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992; 112: 515 ‐ 521.en_US
dc.identifier.citedreferenceBismuth H, Chiche L, Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995; 19: 35 ‐ 41.en_US
dc.identifier.citedreferenceSmalley SR, Moertel CG, Hilton JF, Weiland LH, Weiand HS, Adson MA, et al. Hepatoma in the noncirrhotic liver. Cancer 1988; 62: 1414 ‐ 1424.en_US
dc.identifier.citedreferenceFong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999; 229: 790 ‐ 799.en_US
dc.identifier.citedreferencePoon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long‐term prognosis after resection of hepatocellular carcinoma associated with hepatitis B‐related cirrhosis. J Clin Oncol 2000; 18: 1094 ‐ 1101.en_US
dc.identifier.citedreferenceShimada M, Rikimaru T, Sugimachi K, Hamatsu T, Yamashita Y, Aishima S, et al. The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg 2000; 191: 531 ‐ 537.en_US
dc.identifier.citedreferenceNagasue N, Ono T, Yamanoi A, Kohno H, El‐Assal ON, Taniura H, Uchida M. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001; 88: 515 ‐ 522.en_US
dc.identifier.citedreferenceBilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, et al.; for International Cooperative Study Group on Hepatocellular Carcinoma. Underlying liver disease, not tumor factors, predicts long‐term survival after resection of hepatocellular carcinoma. Arch Surg 2001; 136: 528 ‐ 535.en_US
dc.identifier.citedreferenceBelghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 2002; 49: 41 ‐ 46.en_US
dc.identifier.citedreferenceChen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, Yu MC, Hung CM. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003; 27: 443 ‐ 447.en_US
dc.identifier.citedreferenceGrazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long‐term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003; 17 ( suppl 2 ): 119 ‐ 129.en_US
dc.identifier.citedreferenceVerhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN. Good outcomes after resection of large hepatocellular carcinoma in the non‐cirrhotic liver. Dig Surg 2004; 21: 380 ‐ 386.en_US
dc.identifier.citedreferenceChang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW. Long‐term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004; 139: 320 ‐ 325.en_US
dc.identifier.citedreferenceLang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, et al. Liver resection for hepatocellular carcinoma in non‐cirrhotic liver without underlying viral hepatitis. Br J Surg 2005; 92: 198 ‐ 202.en_US
dc.identifier.citedreferenceDupont‐Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte‐Thirouard AS, Boudjema K. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 2005; 201: 663 ‐ 670.en_US
dc.identifier.citedreferenceLaurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac‐Sage P, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005; 201: 656 ‐ 662.en_US
dc.identifier.citedreferenceCapussotti L, Muratore A, Amisano M, Massucco P, Polastri R, Bouzari H. Liver resection for large‐size hepatocellular carcinomas in 47 non‐cirrhotic patients—no mortality and long‐term survival. Hepatogastroenterology 2006; 53: 768 ‐ 772.en_US
dc.identifier.citedreferenceEguchi S, Ijtsma AJ, Slooff MJ, Porte RJ, de Jong KP, Peeters PM, et al. Outcome and pattern of recurrence after curative resection for hepatocellular carcinoma in patients with a normal liver compared to patients with a diseased liver. Hepatogastroenterology 2006; 53: 592 ‐ 596.en_US
dc.identifier.citedreferenceTaura K, Ikai I, Hatano E, Yasuchika K, Nakajima A, Tada M, et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 2007; 142: 685 ‐ 694.en_US
dc.identifier.citedreferenceHubert C, Sempoux C, Rahier J, Horsmans Y, Geubel A, Van Beers BE, et al. Prognostic risk factors of survival after resection of hepatocellular carcinoma. Hepatogastroenterology 2007; 54: 1791 ‐ 1797.en_US
dc.identifier.citedreferenceBège T, Le Treut YP, Hardwigsen J, Ananian P, Richa H, Campan P, Garcia S. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116‐case European series. J Gastrointest Surg 2007; 11: 619 ‐ 625.en_US
dc.identifier.citedreferenceLubrano J, Huet E, Tsilividis B, François A, Goria O, Riachi G, Scotté M. Long‐term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 2008; 32: 104 ‐ 109.en_US
dc.identifier.citedreferenceRayya F, Harms J, Bartels M, Uhlmann D, Hauss J, Fangmann J. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis. Transplant Proc 2008; 40: 933 ‐ 935.en_US
dc.identifier.citedreferenceXu L, Huang L, Li BK, Zhang YQ, Li JQ, Yuan YF. Clinicopathologic features and long‐term outcomes of Chinese patients with hepatocellular carcinoma in non‐cirrhotic liver. Dig Surg 2008; 25: 376 ‐ 382.en_US
dc.identifier.citedreferenceSotiropoulos GC, Bockhorn M, Sgourakis G, Brokalaki EI, Molmenti EP, Neuhäuser M, et al. R0 liver resections for primary malignant liver tumors in the noncirrhotic liver: a diagnosis‐related analysis. Dig Dis Sci 2009; 54: 887 ‐ 894.en_US
dc.identifier.citedreferenceSmoot RL, Nagorney DM, Chandan VS, Que FG, Schleck CD, Harmsen WS, Kendrick ML. Resection of hepatocellular carcinoma in patients without cirrhosis. Br J Surg 2011; 98: 697 ‐ 703.en_US
dc.identifier.citedreferenceMakuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990; 107: 521 ‐ 527.en_US
dc.identifier.citedreferenceTorzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M, Makuuchi M. Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg 2006; 93: 1238 ‐ 1246.en_US
dc.identifier.citedreferenceKokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am 2004; 84: 643 ‐ 657.en_US
dc.identifier.citedreferenceKishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009; 250: 540 ‐ 548.en_US
dc.identifier.citedreferenceHouben KW, McCall JL. Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 1999; 5: 91 ‐ 95.en_US
dc.identifier.citedreferenceMergental H, Porte RJ. Liver transplantation for unresectable hepatocellular carcinoma in patients without liver cirrhosis. Transpl Int 2010; 23: 662 ‐ 667.en_US
dc.identifier.citedreferenceMergental H, Adam R, Kalicinski P, Ericzon BG, Friman S, Köningsrainer A, et al. Liver transplantation for hepatocellular carcinoma in non‐cirrhotic livers [abstract]. Liver Transpl 2007; 13 ( suppl 1 ): S119.en_US
dc.identifier.citedreferencePichlmayr R, Weimann A, Oldhafer KJ, Schlitt HJ, Klempnauer J, Bornscheuer A, et al. Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 1995; 19: 807 ‐ 813.en_US
dc.identifier.citedreferenceFigueras J, Ramos E, Ibañez L, Rafecas A, Fabregat J, Torras J, et al. Surgical treatment of hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Transplant Proc 1999; 31: 2455 ‐ 2456.en_US
dc.identifier.citedreferenceSchlitt HJ, Neipp M, Weimann A, Oldhafer KJ, Schmoll E, Boeker K, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17: 324 ‐ 331.en_US
dc.identifier.citedreferencePinna AD, Iwatsuki S, Lee RG, Todo S, Madariaga JR, Marsh JW, et al. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology 1997; 26: 877 ‐ 883.en_US
dc.identifier.citedreferenceEl‐Gazzaz G, Wong W, El‐Hadary MK, Gunson BK, Mirza DF, Mayer AD, et al. Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 2000; 13 ( suppl 1 ): S406 ‐ S409.en_US
dc.identifier.citedreferenceEl‐Serag HB, Davila JA. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population‐based study. Hepatology 2004; 39: 798 ‐ 803.en_US
dc.identifier.citedreferenceKakar S, Burgart LJ, Batts KP, Garcia J, Jain D, Ferrell LD. Clinicopathologic features and survival in fibrolamellar carcinoma: comparison with conventional hepatocellular carcinoma with and without cirrhosis. Mod Pathol 2005; 18: 1417 ‐ 1423.en_US
dc.identifier.citedreferenceKatzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Qu W, Douglass EC, et al. Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer 2003; 97: 2006 ‐ 2012.en_US
dc.identifier.citedreferenceStipa F, Yoon SS, Liau KH, Fong Y, Jarnagin WR, D'Angelica M, et al. Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 2006; 106: 1331 ‐ 1338.en_US
dc.identifier.citedreferencePatt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon alfa‐2b for treatment of hepatocellular carcinoma. J Clin Oncol 2003; 21: 421 ‐ 427.en_US
dc.identifier.citedreferenceManiaci V, Davidson BR, Rolles K, Dhillon AP, Hackshaw A, Begent RH, Meyer T. Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol 2009; 35: 617 ‐ 621.en_US
dc.identifier.citedreferenceVivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, et al. Effect of different immunosuppressive schedules on recurrence‐free survival after liver transplantation for hepatocellular carcinoma. Transplantation 2010; 89: 227 ‐ 231.en_US
dc.identifier.citedreferenceSchnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, et al. A prospective randomised, open‐labeled, trial comparing sirolimus‐containing versus mTOR‐inhibitor‐free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer 2010; 10: 190.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
22393_ftp.pdf
Size:
114.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.